Find patient medical information for Tamoxifen on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

July 29, 2011— -- For women diagnosed with hormone-sensitive breast cancer-- more than 150,000 in the U.S. each year-- five years of tamoxifen treatment can dramatically cut the risk of death ...

Tamoxifen is a medication that blocks the female hormone estrogen in the body. For more than 30 years, doctors have prescribed it to fight breast cancer tumors that depend on estrogen to grow ...

A daily medication relied on by more than half a million women is under urgent recall after a critical test failure raised ...

In women who take tamoxifen for 10 years, the risk of endometrial cancer is twice as high as the risk in women who take tamoxifen for 5 years,” it said.

For more than 25 years, tamoxifen has been the gold standard for the endocrine treatment of all stages of oestrogen-receptor-positive breast cancer, and the World Health Organization lists ...

Tamoxifen also reduced the risk for invasive recurrence in the same breast, with a 15-year invasive IBR rate of 11.5% in the no tamoxifen group vs 6% in the yes tamoxifen group.

Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.